Contributor ship
Conceptualization: H. H, A.J, Data curation: A.J, F. P, Formal analysis: F. P, Funding acquisition: A.J, H. H, Investigation: A.J, H. H, S. S. M, Methodology: A.J, H. H, M. A, E. E, H. B, Project administration: A.J, S. S. M, Software: A.J, F. P , Validation: H. H, M. A, E. E, H. B, Visualization: H. H, M. A, E. E, H. B, Writing – original draft: A.J, H. H, Writing – review & editing: A.J, H. H, N. A. G
Reference :
1. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. New England Journal of Medicine. 2020.
2. Luo S, Zhang X, Xu H. Don’t overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19). Clinical Gastroenterology and Hepatology. 2020;18(7):1636.
3. Shen K, Yang Y, Wang T, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World journal of pediatrics. 2020:1-9.
4. Cai J, Xu J, Lin D, et al. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features.Clinical Infectious Diseases. 2020.
5. Li W, Yang Y, Liu Z-H, et al. Progression of mental health services during the COVID-19 outbreak in China. International journal of biological sciences. 2020;16(10):1732.
6. Bellino S, Punzo O, Rota MC, et al. COVID-19 disease severity risk factors for pediatric patients in Italy. Pediatrics. 2020;146(4).
7. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6).
8. Wu H, Zhu H, Yuan C, et al. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China. JAMA Network Open. 2020;3(6):e2010895-e2010895.
9. Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine. 2020;24:100433.
10. Stebbing J, Phelan A, Griffin I, et al. COVID-19: combining antiviral and anti-inflammatory treatments. The Lancet Infectious Diseases. 2020;20(4):400-402.
11. Wang Y, Zhu L-Q. Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019. World Journal of Pediatrics. 2020:1-4.
12. Fatima U, Rizvi SSA, Fatima S, Hassan MI. Impact of hydroxychloroquine/chloroquine in COVID-19 therapy: two sides of the coin. Journal of Interferon & Cytokine Research.2020;40(10):469-471.
13. Cao B, Wang Y, Wen D, et al. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. New England Journal of Medicine. 2020.